Laporan Keuangan Ringkasan laba rugi, neraca, dan arus kas — OMED PT Jayamas Medica Industri Tbk
| Dalam Jutaan IDR | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total Pendapatan | 572,248 | 2,063,817 | 1,469,894 | 925,846 | 436,315 | 1,885,822 | 1,364,495 | 879,648 | 427,388 |
| Total Beban Pokok Penjualan | (366,319) | (1,346,321) | (971,608) | (613,077) | (289,433) | (1,261,846) | (917,534) | (587,601) | (288,687) |
| Laba Kotor | 205,929 | 717,496 | 498,286 | 312,769 | 146,883 | 623,976 | 446,961 | 292,047 | 138,702 |
| Total Beban Usaha | (93,970) | (326,599) | (231,991) | (150,061) | (80,144) | (275,502) | (197,141) | (132,131) | (60,486) |
| Laba Usaha | 111,959 | 390,896 | 266,295 | 162,708 | 66,738 | 348,473 | 249,820 | 159,916 | 78,216 |
| Penghasilan/Beban Lain-Lain | 15,246 | 64,033 | 51,994 | 30,520 | 26,362 | 45,553 | 15,847 | 22,360 | 3,974 |
| Laba Sebelum Pajak | 127,205 | 454,929 | 318,289 | 193,228 | 93,100 | 394,026 | 265,667 | 182,276 | 82,190 |
| Beban Pajak Penghasilan | (28,240) | (85,986) | (62,518) | (38,548) | (20,013) | (70,074) | (53,069) | (37,037) | (18,108) |
| Laba Bersih Dari Operasi Yang Dilanjutkan | 98,965 | 368,943 | 255,771 | 154,680 | 73,087 | 323,952 | 212,598 | 145,239 | 64,082 |
| Hak Minoritas | - | - | - | - | - | - | - | - | - |
| Penyesuaian Proforma | - | - | - | - | - | - | - | - | - |
| Laba Bersih Tahun Berjalan | 98,965 | 368,943 | 255,771 | 154,680 | 73,087 | 323,952 | 212,598 | 145,239 | 64,082 |
| Pendapatan Komprehensif Lain | - | (1,867) | - | - | - | (642) | - | - | - |
| Jumlah Laba Komprehensif | 98,965 | 367,076 | 255,771 | 154,680 | 73,087 | 323,310 | 212,598 | 145,239 | 64,082 |
| Laba Bersih Yang Dapat Diatribusikan | 98,965 | 368,943 | 255,771 | 154,680 | 73,087 | 323,952 | 212,598 | 145,239 | 64,082 |
| Laba Komprehensif Yang Dapat Diatribusikan | 98,965 | 367,076 | 255,771 | 154,680 | 73,087 | 323,310 | 212,598 | 145,239 | 64,082 |
Key Ratios — OMED
| Rasio | Q1 2026 ×4 | Q4 2025 | Q3 2025 ×1⅓ | Q2 2025 ×2 | Q1 2025 ×4 | Q4 2024 | Q3 2024 ×1⅓ | Q2 2024 ×2 | Q1 2024 ×4 |
|---|---|---|---|---|---|---|---|---|---|
| Profitabilitas | |||||||||
| Gross Margin (%) | 35.99% | 34.77% | 33.90% | 33.78% | 33.66% | 33.09% | 32.76% | 33.20% | 32.45% |
| Operating Margin (%) | 19.56% | 18.94% | 18.12% | 17.57% | 15.30% | 18.48% | 18.31% | 18.18% | 18.30% |
| Net Margin (%) | 17.19% | 17.78% | 17.29% | 16.60% | 16.68% | 17.06% | 15.46% | 16.36% | 14.85% |
| ROE (%) | 13.96% | 13.49% | 12.97% | 12.22% | 11.49% | 13.07% | 11.96% | 12.60% | 11.13% |
| ROA (%) | 11.85% | 11.47% | 11.17% | 10.84% | 9.91% | 11.39% | 10.26% | 10.56% | 9.59% |
| Per Lembar Saham | |||||||||
| EPS (Rp) | 14,54 | 13,56 | 12,53 | 11,36 | 10,76 | 11,89 | 10,39 | 10,64 | 9,38 |
| BVPS (Rp) | 104,17 | 100,54 | 96,57 | 93,01 | 93,65 | 90,96 | 86,89 | 84,42 | 84,32 |
| Valuasi | |||||||||
| PER (x) | 14.44x | 15.49x | 16.76x | 18.49x | 19.52x | 17.66x | 20.21x | 19.74x | 22.39x |
| PBV (x) | 2.02x | 2.09x | 2.17x | 2.26x | 2.24x | 2.31x | 2.42x | 2.49x | 2.49x |
| Struktur Modal | |||||||||
| DER (x) | 0.16x | 0.16x | 0.15x | 0.11x | 0.14x | 0.13x | 0.15x | 0.18x | 0.15x |